Directory

>

Rogério Vivaldi Md

avatar

Rogério Vivaldi Md

Member Board of Directors | Crinetics Pharmaceuticals

Cambridge, Massachusetts, United States

View contact details (it's free)

Rogério Vivaldi Md

Summary

Dr. Rogério Vivaldi is an accomplished leader in the pharmaceutical and biotechnology sectors, with a unique blend of medical and business expertise. He holds an MBA and has a rich background in biologics, clinical development, and market access, particularly in the context of rare diseases and neurology. As a board member for multiple companies, including Viatris and Crinetics Pharmaceuticals, he leverages his extensive experience to drive innovation and strategic growth. His tenure as CEO at Sigilon Therapeutics underscores his commitment to pioneering new therapies that address significant unmet medical needs. With a career spanning over two decades, Rogério has consistently held senior leadership roles, shaping the landscape of therapeutic operations and commercialization. He is passionate about advancing Living Therapeutics, which promise safer and more effective treatments compared to traditional gene therapies. His work aims to enhance patient outcomes while navigating the complexities of regulatory affairs and market dynamics.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Rogério Vivaldi Md

Work Experience

company logo

Member Board of Directors at

Viatris, Inc.

June 2024 - Present

company logo

Board Member at

Vesper Biotechnologies

January 2024 - Present

💼

CEO at

Vivaldi Rare Consulting

January 2024 - Present

company logo

Board Member at

Crinetics Pharmaceuticals

January 2022 - Present

company logo

Board Member at

Latinos in Bio

July 2021 - Present

company logo

President, CEO at

Sigilon Therapeutics, Inc.

August 2018 - September 2023

company logo

Chief Global Therapeutic Operations Officer at

Bioverativ, a Sanofi company

October 2016 - August 2018

company logo

Chief Commercial Officer at

Spark Therapeutics, Inc.

December 2014 - October 2016

company logo

President & CEO at

Minerva Neurosciences

November 2013 - December 2014

company logo

SVP, Head of Rare Diseases at

Sanofi

January 2012 - October 2013

company logo

President, Personalized Genetic Health (PGH) at

SANOFI-AVENTIS AUSTRALIA PTY LTD

July 2011 - December 2011

company logo

President, Renal & Endocrine at

Sanofi Genzyme

May 2010 - July 2011

company logo

Senior Vice President & General Manager, Latin America Group at

SANOFI-AVENTIS AUSTRALIA PTY LTD

January 2005 - May 2010

company logo

President, Chief Executive Officer at

Sigilon Therapeutics, Inc.

Present

company logo

Vice President & General manager Genzyme Brasil at

Sanofi Genzyme

January 1997 - December 2004

Logos provided by Logo.dev

Rogério Vivaldi Md

Education

Universidade Federal do Rio de Janeiro, Master Of Business Administration (Mba)

January 1997 - January 1997

UNIVERSIDADE DO RIO DE JANEIRO, Medicine

January 1981 - January 1987

Frequently Asked Questions about Rogério Vivaldi Md

What is Rogério Vivaldi Md email address?

Rogério Vivaldi Md's primary email address is ********@sigilon.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Rogério Vivaldi Md work for?

Rogério Vivaldi Md is a Member Board of Directors at Crinetics Pharmaceuticals, a company specializing in Commercial physical research.

Where Rogério Vivaldi Md graduated from?

Rogério Vivaldi Md holds a degree in Mba from Universidade Federal do Rio de Janeiro.

How can I directly contact Rogério Vivaldi Md?

To contact Rogério Vivaldi Md directly, you can use the email address ********@sigilon.com. Complete contact information is available upon registration with Muraena.

Is Rogério Vivaldi Md an immigrant?

Yes, Rogério Vivaldi Md is an immigrant and currently based in United States

Who is Rogério Vivaldi Md?

Dr. Rogério Vivaldi is an accomplished leader in the pharmaceutical and biotechnology sectors, with a unique blend of medical and business expertise. He holds an MBA and has a rich background in biologics, clinical development, and market access, particularly in the context of rare diseases and neurology. As a board member for multiple companies, including Viatris and Crinetics Pharmaceuticals, he leverages his extensive experience to drive innovation and strategic growth. His tenure as CEO at Sigilon Therapeutics underscores his commitment to pioneering new therapies that address significant unmet medical needs. With a career spanning over two decades, Rogério has consistently held senior leadership roles, shaping the landscape of therapeutic operations and commercialization. He is passionate about advancing Living Therapeutics, which promise safer and more effective treatments compared to traditional gene therapies. His work aims to enhance patient outcomes while navigating the complexities of regulatory affairs and market dynamics.

Rogério`s contact details

mail

********@sigilon.com

***************@genzyme.com

*********@crinetics.com

Colleagues

avatar
Natalie Rossignol

Vice President, Project, Portfolio and Alliance Management

avatar
Omar Hamdy

Chief of Staff and Head of Portfolio Strategy

avatar
Giovanna Matthews

Vice President of Market Access

avatar
Brian Russell

Executive Director, Head of Corporate Strategy

avatar
Stephen Betz

Scientific Advisory Board Member

avatar
Tiffany Quock Ms

Vice President, Health Economics and Outcomes Research

avatar
Michael Keeley

Biopharmaceutical Program Leader

avatar
Michael Monahan

Vice President, Regulatory Affairs and Quality Assurance

avatar
Sameer Goregaoker

Vice President, Marketing - Rare Diseases

avatar
Stacey Harte

Vice President, Global Product Lead

View Contact details (it's free)
Request Profile Removal